Danimer Scientific, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 10.95 million compared to USD 10.45 million a year ago. Net loss was USD 40.16 million compared to USD 94.88 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to USD 0.94 a year ago.
For the nine months, revenue was USD 35.74 million compared to USD 37.89 million a year ago. Net loss was USD 116.04 million compared to USD 151.71 million a year ago. Basic loss per share from continuing operations was USD 1.14 compared to USD 1.5 a year ago.